Clinical trial
Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis: A Pilot Withdrawal/Reinstitution Trial
NCT01088607 is registered in ClinicalTrials.gov with University of Tennessee as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis: A Pilot Withdrawal/Reinstitution Trial
- Lead sponsor
- University of Tennessee
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- October 31, 2010
- Completion date
- June 30, 2017
- Enrollment
- 27 (actual)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.
primary sclerosing cholangitis